Table 3.
Open in new tab

Rate of PD-L1 positivity by specimen site of tested tissue in TNBC using DAKO 22C3 PD-L1 IHC assay.

Specimen sitePD-L1 +Total
Lung5 (71%)7
Lymph node19 (66%)29
Breast36 (57%)63
Abdominal wall1 (50%)2
Pleura1 (50%)2
Skin4 (44%)9
Chest wall 2 (40%)5
Soft tissue1 (33%)3
Liver2 (17%)12
Brain 0 (0%)3
Bone0 (0%)2
Spine 0 (0%)1
Pelvis 0 (0%)1
Trachea 0 (0%)1
Head and neck 0 (0%)1
Bone marrow 0 (0%)1
Specimen sitePD-L1 +Total
Lung5 (71%)7
Lymph node19 (66%)29
Breast36 (57%)63
Abdominal wall1 (50%)2
Pleura1 (50%)2
Skin4 (44%)9
Chest wall 2 (40%)5
Soft tissue1 (33%)3
Liver2 (17%)12
Brain 0 (0%)3
Bone0 (0%)2
Spine 0 (0%)1
Pelvis 0 (0%)1
Trachea 0 (0%)1
Head and neck 0 (0%)1
Bone marrow 0 (0%)1
Table 3.
Open in new tab

Rate of PD-L1 positivity by specimen site of tested tissue in TNBC using DAKO 22C3 PD-L1 IHC assay.

Specimen sitePD-L1 +Total
Lung5 (71%)7
Lymph node19 (66%)29
Breast36 (57%)63
Abdominal wall1 (50%)2
Pleura1 (50%)2
Skin4 (44%)9
Chest wall 2 (40%)5
Soft tissue1 (33%)3
Liver2 (17%)12
Brain 0 (0%)3
Bone0 (0%)2
Spine 0 (0%)1
Pelvis 0 (0%)1
Trachea 0 (0%)1
Head and neck 0 (0%)1
Bone marrow 0 (0%)1
Specimen sitePD-L1 +Total
Lung5 (71%)7
Lymph node19 (66%)29
Breast36 (57%)63
Abdominal wall1 (50%)2
Pleura1 (50%)2
Skin4 (44%)9
Chest wall 2 (40%)5
Soft tissue1 (33%)3
Liver2 (17%)12
Brain 0 (0%)3
Bone0 (0%)2
Spine 0 (0%)1
Pelvis 0 (0%)1
Trachea 0 (0%)1
Head and neck 0 (0%)1
Bone marrow 0 (0%)1
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close